Clinical Trial

The Use of Cannabidiol Suppositories for Sexual Pain

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Research aim: To determine how cannabidiol suppositories might reduce sexual pain during intimacy. Outcomes are also hoped to increase sexual functioning, well-being, and quality of life. Research intention: If cannabidiol suppository intervention reduces sexual pain and increases general well-being, then this research would be repeated on a larger scale, targeting psychosexual services. A brief overview of the intervention: Quantitatively, randomisation of cannabidiol suppositories will be into dose-specific groups. The intervention will be delivered over a period of one month, with follow-up scheduled at 12 weeks. Qualitatively, participants were asked approximately eight open-ended feedback questions throughout the study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-25; most recent amendment 2026-01-23.
Status change: Not Yet Recruiting → Recruiting 2026-01-23
Trial Details
NCT Number NCT07271030
Lead Sponsor London Metropolitan University
Conditions Well-Being, Psychological, Quality of Life, Sexual Behavior, Sexual Pain Disorder
Enrollment 50 participants
Start Date 2026-01-16
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-01-26